2025 Q3 -tulosraportti
63 päivää sitten42 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
139 978
Myynti
Määrä
115 109
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,224VWAP
Alin
0,205VaihtoMäärä
1,5 7 113 401
VWAP
Ylin
0,224Alin
0,205VaihtoMäärä
1,5 7 113 401
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·15 t sitten · Muokattuhttps://www.youtube.com/watch?v=BI2P6nBNMvw&t=740s It can be seen as just an opinion. But this is probably the first time I really hear Jeff Boercherdinger say that the test is almost "guaranteed" to provide good enough accuracy. "Proven to be accurate" are the words he uses. "Limited risk around the product" and "very enthusiastic response to the launch". "adopted in Numerous centers already". "I wish to share more information about that in February, when we announce the full year 2025 results" He still maintains that they will apply for Medicare in mid-2026, no change on that point. I am left with the impression from question 1: that Jeff describes medicaid as a poor man's thing without putting that label on it, and that it is medicare that means the most for Immunovia (is that the insured then) !? So he thinks that medicaid, which will take years anyway, has little significance. Question 2 about "investment sentiment picking up": Yes "mood is improving", Acquisitions are somewhat new in the sector and more common in pharma, but it is a signal that can lead to further acquisitions. You haven't seen as many acquisitions in the diagnostics sector, but when it opens up a bit, more interest in Immunovia among investors can be seen. Question 3 about "tariffs": Minimal impact. Small ingredient productions in countries like Germany. Question 4 about whether the California news will provide the first commercial revenues already for Q1 2026: Expects that multiple centers will sign up to use the test. Usual sequence for how things tend to settle: Enter into an agreement with the center, a period of time where they implement the test, and start using it. Then you start to see volume increase. Regarding the revenue part, it will depend on the invoicing we do at the beginning of this year. They start early with invoicing to see if they can get some "reimbursements before we have formal coverage decisions". So he thinks we have to wait and see "how things play out". And that it will have an impact for California as well, as in other states. Question 5 about reverse split of the stock. If the board and larger shareholders now see significant potential for share price increases now that you are on the verge of commercial rollout in the USA? Answer: RS was concluded. Timing signals from shareholders. Bullish on Immunovia, much value in the company. This is poorly reflected in the share price and "in the market capatilization of the company. When you look at the fact that this is a large market with a big unmet need. We have an excisting product. We have had good clinical results behind it and we are getting good feedback from the market. So we do um we do see good opportunity going forward. Slightly unfortunate closing of his eyes when he said the last sentence about "good opportunity" (body language). One might perhaps think that he is sad about what is happening on the streets with the ICE bullies, or? Wouldn't surprise me..- ·1 päivä sitten · MuokattuI myself believe there is money in a cancer blood test. But today's government in the USA is "very special". So there are probably other markets in the world, one would think? But that happens only after the USA? And there is a certain burn rate now, and how will that go then? https://forum.placera.se/bolag/immunovia Now she is posting extra actively again. At least be a little aware that Elvira on the Placera forum was one of several who hyped the stock between the emission in May 2025 and the next emission autumn 2025. It could be pure naivety. But I myself have lost money on that crowd who go on like that talking about partnerships in the east and in the west. But of course, one day a partnership might come. But no one knows when. One might get news about negotiations, for example, but then everyone will be informed at the same time.
·19 t sittenI still think the stock seems tremendously controlled.·16 t sittenIt's probably easier to control the price where they want when there is low trading volume too. Don't forget that. - ·1 päivä sittenReminder: So, not until 19:20 CET can we see/hear anything Immunovia has to tell.
·23.1.News: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”- ·21.1. · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
63 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·15 t sitten · Muokattuhttps://www.youtube.com/watch?v=BI2P6nBNMvw&t=740s It can be seen as just an opinion. But this is probably the first time I really hear Jeff Boercherdinger say that the test is almost "guaranteed" to provide good enough accuracy. "Proven to be accurate" are the words he uses. "Limited risk around the product" and "very enthusiastic response to the launch". "adopted in Numerous centers already". "I wish to share more information about that in February, when we announce the full year 2025 results" He still maintains that they will apply for Medicare in mid-2026, no change on that point. I am left with the impression from question 1: that Jeff describes medicaid as a poor man's thing without putting that label on it, and that it is medicare that means the most for Immunovia (is that the insured then) !? So he thinks that medicaid, which will take years anyway, has little significance. Question 2 about "investment sentiment picking up": Yes "mood is improving", Acquisitions are somewhat new in the sector and more common in pharma, but it is a signal that can lead to further acquisitions. You haven't seen as many acquisitions in the diagnostics sector, but when it opens up a bit, more interest in Immunovia among investors can be seen. Question 3 about "tariffs": Minimal impact. Small ingredient productions in countries like Germany. Question 4 about whether the California news will provide the first commercial revenues already for Q1 2026: Expects that multiple centers will sign up to use the test. Usual sequence for how things tend to settle: Enter into an agreement with the center, a period of time where they implement the test, and start using it. Then you start to see volume increase. Regarding the revenue part, it will depend on the invoicing we do at the beginning of this year. They start early with invoicing to see if they can get some "reimbursements before we have formal coverage decisions". So he thinks we have to wait and see "how things play out". And that it will have an impact for California as well, as in other states. Question 5 about reverse split of the stock. If the board and larger shareholders now see significant potential for share price increases now that you are on the verge of commercial rollout in the USA? Answer: RS was concluded. Timing signals from shareholders. Bullish on Immunovia, much value in the company. This is poorly reflected in the share price and "in the market capatilization of the company. When you look at the fact that this is a large market with a big unmet need. We have an excisting product. We have had good clinical results behind it and we are getting good feedback from the market. So we do um we do see good opportunity going forward. Slightly unfortunate closing of his eyes when he said the last sentence about "good opportunity" (body language). One might perhaps think that he is sad about what is happening on the streets with the ICE bullies, or? Wouldn't surprise me..
- ·1 päivä sitten · MuokattuI myself believe there is money in a cancer blood test. But today's government in the USA is "very special". So there are probably other markets in the world, one would think? But that happens only after the USA? And there is a certain burn rate now, and how will that go then? https://forum.placera.se/bolag/immunovia Now she is posting extra actively again. At least be a little aware that Elvira on the Placera forum was one of several who hyped the stock between the emission in May 2025 and the next emission autumn 2025. It could be pure naivety. But I myself have lost money on that crowd who go on like that talking about partnerships in the east and in the west. But of course, one day a partnership might come. But no one knows when. One might get news about negotiations, for example, but then everyone will be informed at the same time.·19 t sittenI still think the stock seems tremendously controlled.·16 t sittenIt's probably easier to control the price where they want when there is low trading volume too. Don't forget that.
- ·1 päivä sittenReminder: So, not until 19:20 CET can we see/hear anything Immunovia has to tell.
- ·23.1.News: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”
- ·21.1. · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
139 978
Myynti
Määrä
115 109
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,224VWAP
Alin
0,205VaihtoMäärä
1,5 7 113 401
VWAP
Ylin
0,224Alin
0,205VaihtoMäärä
1,5 7 113 401
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
2025 Q3 -tulosraportti
63 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·15 t sitten · Muokattuhttps://www.youtube.com/watch?v=BI2P6nBNMvw&t=740s It can be seen as just an opinion. But this is probably the first time I really hear Jeff Boercherdinger say that the test is almost "guaranteed" to provide good enough accuracy. "Proven to be accurate" are the words he uses. "Limited risk around the product" and "very enthusiastic response to the launch". "adopted in Numerous centers already". "I wish to share more information about that in February, when we announce the full year 2025 results" He still maintains that they will apply for Medicare in mid-2026, no change on that point. I am left with the impression from question 1: that Jeff describes medicaid as a poor man's thing without putting that label on it, and that it is medicare that means the most for Immunovia (is that the insured then) !? So he thinks that medicaid, which will take years anyway, has little significance. Question 2 about "investment sentiment picking up": Yes "mood is improving", Acquisitions are somewhat new in the sector and more common in pharma, but it is a signal that can lead to further acquisitions. You haven't seen as many acquisitions in the diagnostics sector, but when it opens up a bit, more interest in Immunovia among investors can be seen. Question 3 about "tariffs": Minimal impact. Small ingredient productions in countries like Germany. Question 4 about whether the California news will provide the first commercial revenues already for Q1 2026: Expects that multiple centers will sign up to use the test. Usual sequence for how things tend to settle: Enter into an agreement with the center, a period of time where they implement the test, and start using it. Then you start to see volume increase. Regarding the revenue part, it will depend on the invoicing we do at the beginning of this year. They start early with invoicing to see if they can get some "reimbursements before we have formal coverage decisions". So he thinks we have to wait and see "how things play out". And that it will have an impact for California as well, as in other states. Question 5 about reverse split of the stock. If the board and larger shareholders now see significant potential for share price increases now that you are on the verge of commercial rollout in the USA? Answer: RS was concluded. Timing signals from shareholders. Bullish on Immunovia, much value in the company. This is poorly reflected in the share price and "in the market capatilization of the company. When you look at the fact that this is a large market with a big unmet need. We have an excisting product. We have had good clinical results behind it and we are getting good feedback from the market. So we do um we do see good opportunity going forward. Slightly unfortunate closing of his eyes when he said the last sentence about "good opportunity" (body language). One might perhaps think that he is sad about what is happening on the streets with the ICE bullies, or? Wouldn't surprise me..
- ·1 päivä sitten · MuokattuI myself believe there is money in a cancer blood test. But today's government in the USA is "very special". So there are probably other markets in the world, one would think? But that happens only after the USA? And there is a certain burn rate now, and how will that go then? https://forum.placera.se/bolag/immunovia Now she is posting extra actively again. At least be a little aware that Elvira on the Placera forum was one of several who hyped the stock between the emission in May 2025 and the next emission autumn 2025. It could be pure naivety. But I myself have lost money on that crowd who go on like that talking about partnerships in the east and in the west. But of course, one day a partnership might come. But no one knows when. One might get news about negotiations, for example, but then everyone will be informed at the same time.·19 t sittenI still think the stock seems tremendously controlled.·16 t sittenIt's probably easier to control the price where they want when there is low trading volume too. Don't forget that.
- ·1 päivä sittenReminder: So, not until 19:20 CET can we see/hear anything Immunovia has to tell.
- ·23.1.News: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”
- ·21.1. · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
139 978
Myynti
Määrä
115 109
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Ylin
0,224VWAP
Alin
0,205VaihtoMäärä
1,5 7 113 401
VWAP
Ylin
0,224Alin
0,205VaihtoMäärä
1,5 7 113 401
Välittäjätilasto
Dataa ei löytynyt